INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 10 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,712,300 | +22.6% | 21,000,000 | 0.0% | 0.01% | +37.5% |
| Q2 2023 | $16,888,196 | -2.7% | 21,000,000 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $17,363,331 | +10.2% | 21,000,000 | 0.0% | 0.01% | +12.5% |
| Q4 2022 | $15,760,500 | -0.6% | 21,000,000 | 0.0% | 0.01% | -11.1% |
| Q3 2022 | $15,863,000 | +14.2% | 21,000,000 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $13,885,000 | +8.1% | 21,000,000 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $12,846,000 | 0.0% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $12,846,000 | +0.9% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,730,000 | -9.6% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,083,000 | -37.7% | 21,000,000 | -39.1% | 0.01% | -44.4% |
| Q1 2021 | $22,622,000 | +9.2% | 34,500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $20,713,000 | -13.9% | 34,500,000 | 0.0% | 0.01% | -25.0% |
| Q3 2020 | $24,060,000 | -6.2% | 34,500,000 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $25,648,000 | -14.1% | 34,500,000 | 0.0% | 0.01% | -35.0% |
| Q1 2020 | $29,870,000 | -35.1% | 34,500,000 | 0.0% | 0.02% | -16.7% |
| Q4 2019 | $45,992,000 | +43.4% | 34,500,000 | -2.8% | 0.02% | +41.2% |
| Q3 2019 | $32,083,000 | +4.1% | 35,500,000 | +14.5% | 0.02% | +6.2% |
| Q2 2019 | $30,830,000 | – | 31,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 2,500,000 | $2,486,000 | 1.44% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $19,894,000 | 1.32% |
| SSI INVESTMENT MANAGEMENT LLC | 6,154,000 | $6,089,000 | 0.45% |
| CSS LLC/IL | 7,750,000 | $7,713,000 | 0.44% |
| Senvest Management, LLC | 5,000,000 | $4,998,000 | 0.44% |
| Antara Capital LP | 2,000,000 | $1,989,000 | 0.43% |
| LINDEN ADVISORS LP | 28,527,000 | $28,380,000 | 0.43% |
| Graham Capital Management, L.P. | 10,650,000 | $10,579,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 19,000,000 | $18,904,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $9,957,000 | 0.18% |